0001127602-24-015369.txt : 20240515 0001127602-24-015369.hdr.sgml : 20240515 20240515071454 ACCESSION NUMBER: 0001127602-24-015369 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240513 FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Galson Steven K CENTRAL INDEX KEY: 0001495328 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 24947128 MAIL ADDRESS: STREET 1: C/O BIOCRYST PHARMACEUTICALS, INC. STREET 2: 4505 EMPEROR BLVD, SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-13 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001495328 Galson Steven K 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 0 Common Stock 2024-05-13 4 P 0 21940 5.49 A 51551 D The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.48 to $5.49. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. /s/ Alane P. Barnes, by power of attorney 2024-05-15